Submitted by Anonymous (not verified) on 3 August 2026 - 12:15
Human medicines European public assessment report (EPAR): Svariya (previously Rivaroxaban Koanaa), rivaroxaban, Date of authorisation: 21/11/2025, Revision: 1, Status: Authorised
Source: